DiaMedica Therapeutics Inc. (DMAC): Price and Financial Metrics

DiaMedica Therapeutics Inc. (DMAC): $2.51

0.12 (+5.02%)

POWR Rating

Component Grades








Add DMAC to Watchlist
Sign Up

Industry: Biotech




#161 of 363

in industry

DMAC Price/Volume Stats

Current price $2.51 52-week high $4.75
Prev. close $2.39 52-week low $1.50
Day low $2.26 Volume 21,100
Day high $2.56 Avg. volume 42,247
50-day MA $2.83 Dividend yield N/A
200-day MA $2.82 Market Cap 95.27M

DMAC Stock Price Chart Interactive Chart >

DiaMedica Therapeutics Inc. (DMAC) Company Bio

DiaMedica Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It offers DM199 product which focuses on acute ischemic stroke (AIS), and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.

DMAC Latest News Stream

Event/Time News Detail
Loading, please wait...

DMAC Latest Social Stream

Loading social stream, please wait...

View Full DMAC Social Stream

Latest DMAC News From Around the Web

Below are the latest news stories about DIAMEDICA THERAPEUTICS INC that investors may wish to consider to help them evaluate DMAC as an investment opportunity.

Here's Why We're Not Too Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Situation

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Yahoo | December 11, 2023

Billionaire Lee Cooperman’s 10 Stock Picks with Huge Upside Potential

In this article, we discuss billionaire Lee Cooperman’s 10 stock picks with huge upside potential. To skip the details of Mr. Cooperman’s life and investment strategy, go directly to Billionaire Lee Cooperman’s 5 Stock Picks with Huge Upside Potential. Leon Cooperman is the true definition of a “self-made” person. He was born in the South […]

Yahoo | December 4, 2023

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings Call Transcript

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Third Quarter 2023 Conference Call. An audio recording of the webcast will be available shortly after the call today on DiaMedica’s website at www.diamedica.com, in the Investor Relations section. Before the […]

Yahoo | November 15, 2023

Q3 2023 DiaMedica Therapeutics Inc Earnings Call

Q3 2023 DiaMedica Therapeutics Inc Earnings Call

Yahoo | November 15, 2023

DiaMedica Therapeutics Inc. (DMAC) Reports Third Quarter 2023 Financial Results

Protocol Amendments and Increased R&D Spending Mark Q3 2023

Yahoo | November 14, 2023

Read More 'DMAC' Stories Here

DMAC Price Returns

1-mo -8.73%
3-mo -6.34%
6-mo 19.81%
1-year 54.94%
3-year -74.23%
5-year -25.07%
YTD -11.62%
2023 79.74%
2022 -57.64%
2021 -63.21%
2020 109.07%
2019 66.67%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!